ARTV smart money
Artiva Biotherapeutics, INC. (ARTV): 10 insider buys, 2 top funds holding it in the public filings.
Insider buys, 12 months$109.1M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-07-31 | Ra Capital Healthcare Fund LP | Director,TenPercentOwner | $456k | $9.93 |
| 2026-07-28 | Ra Capital Nexus Fund III, L.P. | Director | $413k | $9.99 |
| 2026-07-23 | Kolchinsky Peter | Director,TenPercentOwner | $2.6M | $9.96 |
| 2026-07-20 | Ra Capital Healthcare Fund LP | Director,TenPercentOwner | $1.4M | $8.95 |
| 2026-07-14 | Shah Rajeev M. | Director,TenPercentOwner | $194k | $8.97 |
| 2026-06-29 | Ra Capital Management, L.P. | Director,TenPercentOwner | $275k | $8.88 |
| 2026-06-16 | Kolchinsky Peter | Director,TenPercentOwner | $4.6M | $8.99 |
| 2026-06-11 | Ra Capital Nexus Fund, L.P. | Director | $7.6M | $7.91 |
| 2026-05-28 | Gc Corp. | TenPercentOwner | $16.5M | $11.52 |
| 2026-05-13 | Ra Capital Nexus Fund III, L.P. | Director | $75.0M | $11.52 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 2 | Venrock Adviser, LLC | 0.71% | $15M | |
| 86 | Adar1 Capital Management, LLC | TRIM -27% | 0.03% | $600k |